World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
60361
World Ranking
9465
National Ranking
918

Peter W. Macfarlane publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter W. Macfarlane sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 503 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter W. Macfarlane D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter W. Macfarlane sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1992 - Fellow of the Royal Society of Edinburgh

Overview

Peter W. Macfarlane is affiliated with the University of Glasgow in the United Kingdom. Their research focus lies primarily within the field of Medicine, with a substantial emphasis on Cardiology and Cardiovascular Medicine. Their work extends into subfields including Radiology, Nuclear Medicine and Imaging, Molecular Biology, Surgery, and Emergency Medicine.

The scientist has contributed extensively to topics such as Cardiac electrophysiology and arrhythmias, ECG Monitoring and Analysis, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Cardiac Arrhythmias and Treatments, Cardiomyopathy and Myosin Studies, and the Long-Term Effects of COVID-19.

Frequent collaborators of Peter W. Macfarlane include Colin Berry, Alex McConnachie, Antônio Luiz Pinho Ribeiro, Naveed Sattar, and Andrew Morrow, reflecting a network of research partnerships across cardiovascular medicine and related disciplines.

Publications by Peter W. Macfarlane appear regularly in several scientific venues. These include:

  • Circulation
  • Journal of Electrocardiology
  • OPAL (Open@LaTrobe) (La Trobe University)
  • Hearts
  • Journal of the American Heart Association

Recent significant papers authored or co-authored by Macfarlane include:

  • Pre-trained deep neural network models for ECG automatic abnormality detection, 2020, OPAL (Open@LaTrobe) (La Trobe University)
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis, 2024, The Lancet Diabetes & Endocrinology
  • Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study, 2023, Circulation
  • A multisystem, cardio-renal investigation of post-COVID-19 illness, 2022, Nature Medicine

In 1992, Peter W. Macfarlane was recognized as a Fellow of the Royal Society of Edinburgh. This distinction marks a longstanding involvement in the scientific community, particularly within areas that intersect cardiology, diagnostics, and the detailed study of cardiac conditions.

Best Publications

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

    J Shepherd;S M Cobbe;I Ford;C G Isles

  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

    James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

    Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford

  • West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

    J Shepherd;SM Cobbe;AR Lorimer;JH McKillop

  • Automatic diagnosis of the 12-lead ECG using a deep neural network

    Antônio H. Ribeiro;Antônio H. Ribeiro;Manoel Horta Ribeiro;Gabriella M.M. Paixão;Derick M. Oliveira

  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

    Jill Belch;Angus MacCuish;Iain Campbell;Stuart Cobbe

  • Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely

  • Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology

    Paul Kligfield;Leonard S. Gettes;James J. Bailey;Rory Childers

  • Practice Standards for Electrocardiographic Monitoring in Hospital Settings An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young

    Barbara J. Drew;Robert M. Califf;Marjorie Funk;Elizabeth S. Kaufman

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation

    Carolina Roselli;Mark D. Chaffin;Lu Chen Weng;Lu Chen Weng;Stefanie Aeschbacher

  • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

    CJ Packard;J Shepherd;SM Cobbe;Jane B Ford

  • Recommendations for the Standardization and Interpretation of the Electrocardiogram

    Paul Kligfield;Leonard S. Gettes;James J. Bailey;Rory Childers

  • Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

    Naveed Sattar;Alex McConnachie;A Gerald Shaper;Gerard J Blauw

  • Long-Term Follow-up of the West of Scotland Coronary Prevention Study

    Ian Ford;Heather Murray;Chris J Packard;James Shepherd

  • Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

    Naveed Sattar;Olga Scherbakova;Ian Ford;Denis St. J. O’Reilly

  • A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

    Shen Luo;Kurt Michler;Paul Johnston;Peter W. Macfarlane

  • The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

    James Shepherd;Gerard Jan Blauw;Michael B Murphy;Stuart M Cobbe

  • AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology

    E. William Hancock;Barbara J. Deal;David M. Mirvis;Peter Okin

Frequent Co-Authors

Ian Ford
Ian Ford University of Glasgow
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Stuart M. Cobbe
Stuart M. Cobbe University of Glasgow
Chris J. Packard
Chris J. Packard Glasgow Royal Infirmary
David J. Stott
David J. Stott University of Glasgow
Stella Trompet
Stella Trompet Leiden University Medical Center
Bruce M. Psaty
Bruce M. Psaty University of Washington
Naveed Sattar
Naveed Sattar University of Glasgow
Rudi G. J. Westendorp
Rudi G. J. Westendorp University of Copenhagen
Albert V. Smith
Albert V. Smith University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The landscape of healthcare education is rapidly evolving, making it easier than ever to pursue medical-related degrees online. For those interested in preventive care and wellness, an online bachelor's degree in nutrition offers a flexible entry point into the field of dietetics and health education.

Aspiring healthcare administrators can enhance their credentials with online mha programs cahme accredited, gaining leadership skills vital for hospital and clinic management. Nurses looking to expand their roles can explore rn to bsn programs without clinicals, which are ideal for working professionals due to their flexible, non-clinical coursework.

For those pursuing advanced practice and leadership in nursing, the fastest msn to dnp program options allow qualified candidates to achieve a doctoral degree in a streamlined format. Exploring these online programs can open new doors and prepare you for diverse, rewarding career paths in the dynamic world of healthcare.

Best Scientists Citing Peter W. Macfarlane

Trending Scientists

Recently Published Articles